Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3311)
All Articles published online
|
Apr 21, 2007 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Asakura H, Suzuki K, Honma T. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007; 13(15): 2145-2149 [PMID: 17465491 DOI: 10.3748/wjg.v13.i15.2145] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i15/2145.htm |
| Number | Citing Articles |
| 1 |
Katia Abdelouhab, Hayet Rafa, Ryma Toumi, Samia Bouaziz, Oussama Medjeber, Chafia Touil-Boukoffa. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics. Immunopharmacology and Immunotoxicology 2012; 34(4): 590 doi: 10.3109/08923973.2011.641971
|
| 2 |
Dong-ha Kim, Ji-Su Kim, Jae-Hee Kwon, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes. Antioxidants 2023; 12(10): 1886 doi: 10.3390/antiox12101886
|
| 3 |
Maciej Chichlowski, Laura P. Hale. Bacterial-mucosal interactions in inflammatory bowel disease—an alliance gone bad. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 295(6): G1139 doi: 10.1152/ajpgi.90516.2008
|
| 4 |
Romy Lauche, Holger Cramer, Petra Klose, Karin Kraft, Gustav J Dobos, Jost Langhorst. Herbal medicines for the treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews 2014; doi: 10.1002/14651858.CD011223
|
| 5 |
Dimitrios Damaskos, George Kolios. Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’. British Journal of Clinical Pharmacology 2008; 65(4): 453 doi: 10.1111/j.1365-2125.2008.03096.x
|
| 6 |
Nada A. Helal, Heba A. Eassa, Ahmed M. Amer, Mohamed A. Eltokhy, Ivan Edafiogho, Mohamed I. Nounou. Nutraceuticals’ Novel Formulations: The Good, the Bad, the Unknown and Patents Involved. Recent Patents on Drug Delivery & Formulation 2019; 13(2): 105 doi: 10.2174/1872211313666190503112040
|
| 7 |
Ulysses dos Santos Torres, Juliana Olsen Rodrigues, Melissa Silva Garcia Junqueira, Simone Uezato, João Gomes Netinho. The Montreal classification for Crohn's disease: clinical application to a Brazilian single-center cohort of 90 consecutive patients. Arquivos de Gastroenterologia 2010; 47(3): 279 doi: 10.1590/S0004-28032010000300013
|
| 8 |
Mahdi Shadnoush, Rahebeh Shaker Hosseini, Ahad Khalilnezhad, Lida Navai, Hossein Goudarzi, Maryam Vaezjalali. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. The Korean Journal of Gastroenterology 2015; 65(4): 215 doi: 10.4166/kjg.2015.65.4.215
|
| 9 |
Bernd B. Frericks, Frank Wacker, Christoph Loddenkemper, Steffi Valdeig, Birgit Hotz, Karl-Jürgen Wolf, Bernd Misselwitz, Anja Kühl, Jörg C. Hoffmann. Magnetic Resonance Imaging of Experimental Inflammatory Bowel Disease. Investigative Radiology 2009; 44(1): 23 doi: 10.1097/RLI.0b013e3181899025
|
| 10 |
Hayet Rafa, Houria Saoula, Mourad Belkhelfa, Oussama Medjeber, Imene Soufli, Ryma Toumi, Yvan de Launoit, Olivier Moralès, M'hamed Nakmouche, Nadira Delhem, Chafia Touil-Boukoffa. IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid. Journal of Interferon & Cytokine Research 2013; 33(7): 355 doi: 10.1089/jir.2012.0063
|
| 11 |
Qi Zhang, Cuiping Zhang, Xiaoyu Li, Yanan Yu, Kun Liang, Xinzhi Shan, Kun Zhao, Qinghui Niu, Zibin Tian. WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/3547096
|
| 12 |
Maricelma da Silva Soares de Souza, Sandra Maria Barbalho, Ricardo de Alvares Goulart, Antonely de Cássio Alves de Carvalho. The Current and Future Role of Drugs and Probiotics in the Management of Inflammatory Bowel Disease. Journal of Biosciences and Medicines 2015; 3(08): 76 doi: 10.4236/jbm.2015.38008
|
| 13 |
Yosuke Nishitani, Koji Yamamoto, Masaru Yoshida, Takeshi Azuma, Kazuki Kanazawa, Takashi Hashimoto, Masashi Mizuno. Intestinal anti‐inflammatory activity of luteolin: Role of the aglycone in NF‐κB inactivation in macrophages co‐cultured with intestinal epithelial cells. BioFactors 2013; 39(5): 522 doi: 10.1002/biof.1091
|
| 14 |
S. He, T. Li, H. Chen, W. Ma, Q. Yao, H. Yang, H. Wang, F. Wang, C. Zhao, P. Yang. CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation. Allergy 2011; 66(2): 238 doi: 10.1111/j.1398-9995.2010.02455.x
|